Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 28;28(28):3586-3594.
doi: 10.3748/wjg.v28.i28.3586.

Update on endoscopic ultrasound-guided liver biopsy

Affiliations
Review

Update on endoscopic ultrasound-guided liver biopsy

Shiva Rangwani et al. World J Gastroenterol. .

Abstract

Endoscopic ultrasound guided liver biopsy (EUS-LB) has emerged as a minimally-invasive alternative to the traditional (percutaneous or transjugular) liver biopsy techniques for the diagnosis of liver parenchymal diseases. Po-tentially, EUS-LB combines the advantages of percutaneous and transjugular liver biopsy in addressing focused sampling in addition to measuring portal pressure. Additionally, EUS-LB facilitates access to both the lobes of the liver which is not considered with the traditional percutaneous liver biopsy. Multiple studies have compared EUS-LB with conventional liver biopsy and reported comparable diagnostic yield, increased acquisition of complete portal tracts, and longer specimen length as compared to the traditional approaches. EUS-LB is associated with lesser post-procedural pain and shorter recovery time, while providing lower risk of complications when compared to traditional liver biopsy. Innovations in needle types, needle sizes and suction techniques have aimed at further optimizing the EUS-LB technique. This review article updates current literature with focus on the variations in the technique and equipment used for EUS-LB, and compares EUS-LB with traditional methods of liver biopsy.

Keywords: Endoscopic ultrasound guided liver biopsy; Liver biopsy; Liver parenchymal disease; Percutaneous liver biopsy; Portal pressure gradient; Transjugular liver biopsy.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Needle for endoscopic ultrasound guided liver biopsy accessing left lobe of the liver. Orange arrow denotes needle. Image obtained by Krishna SG at the Ohio State University Wexner Medical Center Division of Gastroenterology, Hepatology, and Nutrition.

References

    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed
    1. Piazzolla VA, Mangia A. Noninvasive Diagnosis of NAFLD and NASH. Cells. 2020;9 - PMC - PubMed
    1. Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156:1264–1281.e4. - PMC - PubMed
    1. McLoughlin MJ, Ho CS, Tao LC. Percutaneous needle aspiration biopsy. Can Med Assoc J. 1978;119:1324–1328. - PMC - PubMed
    1. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995;36:437–441. - PMC - PubMed

MeSH terms